hgh and cancer risk GH treatment may increase an individual's risk of developing cancer - Long term low doseHGH There was significantly raised risk of both cancer mortality and incidence HGH and Cancer Risk: Understanding the Complex Relationship

HGHside effects The relationship between human growth hormone (hGH) and cancer risk is a topic of ongoing scientific investigation and public interest.Growth hormone, the insulin-like growth factor axis ... While growth hormone plays a vital role in childhood development and various metabolic functions in adults, its potential carcinogenic effects have been a subject of numerous studies. Understanding the nuances of hGH use, high GH levels, and their association with cancer requires a thorough examination of the available evidence.8 Acromegaly, growth hormone and cancer risk

The Biological Basis: Growth Hormone and Cell Proliferation

Growth hormone (GH) exerts many of its effects indirectly through the insulin-like growth factor (IGF) axis. IGF-1, a key mediator, is a potent mitogen, meaning it promotes cell division and growth. This inherent property raises concerns because uncontrolled cell proliferation is a hallmark of cancer. The high levels of a growth factor increases risk for several cancers have been observed in various contexts, suggesting a biological plausibility for a link between elevated GH and increased cancer risk.

Evidence from Acromegaly Studies

Individuals with acromegaly, a condition characterized by the body producing too much growth hormone after the growth plates have closed, offer a unique window into the potential hGH and cancer risk connection佛历2568年7月14日—People with the raregrowth hormonedisorder acromegaly have a significantly higherriskof developing various types ofcancer.. Epidemiological studies of patients with acromegaly consistently indicate an increased risk of colorectal cancerGrowth hormone in childhood does not increase later .... Some research also points towards an elevated risk in gastric, breast, and urinary tract cancer in these individualsGrowth hormone, the insulin-like growth factor axis .... While the association with colorectal cancer is well-described, the risks of other cancers remain less definitively proven, though some findings suggest they may also increase. It is generally accepted that acromegaly is associated with a slightly elevated risk of cancer.

Growth Hormone Therapy and Cancer Risk: A Deeper Dive

The use of growth hormone therapy, particularly recombinant human growth hormone (r-hGH), for conditions like growth hormone deficiency (GHD) has also been scrutinized for potential cancer-related effects作者：Z Li·2016·被引用次数：31—Our study suggests thatgrowth hormone replacement therapy could reduce risk of cancerin adult with growth hormone deficiency..

* Childhood Treatment: Many studies focusing on children treated with r-hGH for conditions such as GHD, small for gestational age (SGA), or idiopathic short stature (ISS) have found that no association was found between rhGH treatment during childhood for GHD, SGA, or ISS and malignant neoplastic events in early to mid-adulthood. The general consensus from these studies is that the risk of cancer is low in children treated with GH, and available evidence suggests an increased risk of secondary tumors in rhGH recipients is not a consistent finding.Strong Muscles, Strong Tumors? Growth hormone's effects ... Some earlier studies on patients treated with human pituitary growth hormone did show significantly raised risks of mortality from cancer overall, but this was linked to the source of the hormone, which was later found to be contaminated. Data on patients who received recombinant human growth hormone (r-hGH) as children "do not generally support a carcinogenic effect of r-hGH."

* Adult Treatment and Cancer Survivors: The implications of GH therapy for adults, especially those with a history of cancer, are more complex. Some research suggests that growth hormone replacement therapy would reduce risk of cancer in adults with growth hormone deficiency.作者：AG Renehan·2008·被引用次数：174—Recent estimates forriskof coloncancerin the acromegalic patients reported at 19.0 and 17.4 for men and women, respectively, from a single institute series ... However, other studies indicate that GH treatment may increase an individual's risk of developing cancer, particularly in the case of cancer survivors, by increasing the risk of recurrence. Despite this, current evidence reviewed from workshops does not support a definitive association between GH replacement and primary tumor or cancer recurrence. Nevertheless, caution is advised, and situations involving giving growth hormone when no deficiency exists might raise the risk of cancer. This highlights the importance of using GH therapy only for approved indications and at recommended dosesIs excess growth hormone associated with increased ....

* Specific Cancers: Certain studies have noted raised risks of colorectal, prostate, and premenopausal breast cancers in relation to greater prior IGF1 levels. Another significant finding is that patients treated with hGH demonstrated a significantly raised risk of both cancer mortality and incidence for cancers of the bone, kidney, central nervous system (CNS), and thyroid. However, it is crucial to note that other comprehensive analyses using large datasets have not found a general carcinogenic effect of r-hGH, though an unexplained trend in cancer mortality risk in relation to prior therapy requires continued observation.作者：PJ Jenkins·2006·被引用次数：248—Epidemiological studies of patients with acromegaly indicate anincreased risk of colorectal cancer, although risk of other cancers is unproven, ...

Safety Profile and Expert Opinions

Despite the potential concerns, many expert opinions and large-scale studies suggest that GH therapy has a good safety profile when used for approved indications and at recommended doses, with no evidence of a significant increase across the board. Some research has even indicated that growth hormone replacement therapy would reduce risk of cancer in adults with GHD. The general view is that growth hormone replacement is considered well-tolerated and not associated with an increased risk of cancer or diabetes when used appropriately. The narrative around Growth Hormone And Cancer Risk is evolving, and it is important to distinguish between naturally occurring high GH levels, therapeutic use for deficiency, and illicit or non-medical use作者：AG Renehan·2008·被引用次数：174—Recent estimates forriskof coloncancerin the acromegalic patients reported at 19.0 and 17.4 for men and women, respectively, from a single institute series ....

Conclusion: Balancing Benefits and Risks

The relationship between HGH and cancer risk is not a simple cause-and-effect scenario. While conditions involving excess growth hormone like acromegaly are linked to a higher incidence of certain cancers, especially colorectal cancer, the evidence for growth hormone therapy in treating deficiencies suggests a more nuanced picture. For children, the risk of cancer appears to be low with r-hGH treatment. For adults, particularly cancer survivors, the decision to use GH therapy requires careful consideration of individual medical history and potential risks. It is essential to rely on medical professionals for accurate diagnosis and treatment plans, ensuring that growth hormone is used safely and effectively for its approved indications作者：AJ Swerdlow·2006·被引用次数：20—Almost all cohort studies showraised risks of colorectal, prostate, and premenopausal breast cancersin relation to greater prior IGF1 levels.. Research continues to refine our understanding of GH and cancer, aiming to provide clearer guidance on its safety and efficacy for various patient populations作者：J Guevara-Aguirre·2023·被引用次数：18—However, recent studies foundincreased risks in gastric, breast, and urinary tract canceralso. Concordantly, clinical situations where GH and ....